Group One Trading’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.01M | Sell |
16,100
-94,800
| -85% | -$6.6M | ﹤0.01% | 2713 |
|
|
2025
Q4 | $7.36M | Sell |
110,900
-18,900
| -15% | -$1.22M | 0.01% | 1173 |
|
|
2025
Q3 | $8.73M | Buy |
129,800
+2,500
| +2% | +$198K | 0.02% | 1005 |
|
|
2025
Q2 | $11.1M | Buy |
127,300
+114,900
| +927% | +$9.01M | 0.02% | 747 |
|
|
2025
Q1 | $847K | Sell |
12,400
-6,500
| -34% | -$530K | ﹤0.01% | 2605 |
|
|
2024
Q4 | $1.47M | Buy |
18,900
+2,200
| +13% | +$163K | ﹤0.01% | 2193 |
|
|
2024
Q3 | $1.12M | Buy |
16,700
+14,500
| +659% | +$1.19M | ﹤0.01% | 2198 |
|
|
2024
Q2 | $249K | Sell |
2,200
-26,600
| -92% | -$3.36M | ﹤0.01% | 3214 |
|
|
2024
Q1 | $3.99M | Sell |
28,800
-35,400
| -55% | -$4.45M | 0.02% | 975 |
|
|
2023
Q4 | $7.97M | Buy |
64,200
+27,200
| +74% | +$2.78M | 0.02% | 826 |
|
|
2023
Q3 | $3.45M | Buy |
37,000
+5,900
| +19% | +$665K | 0.01% | 1192 |
|
|
2023
Q2 | $4M | Buy |
31,100
+3,000
| +11% | +$363K | 0.01% | 1143 |
|
|
2023
Q1 | $3.26M | Sell |
28,100
-110,400
| -80% | -$12.4M | 0.01% | 1135 |
|
|
2022
Q4 | $15.7M | Sell |
138,500
-12,700
| -8% | -$1.39M | 0.04% | 502 |
|
|
2022
Q3 | $12.2M | Buy |
151,200
+12,000
| +9% | +$1.02M | 0.02% | 627 |
|
|
2022
Q2 | $10.4M | Sell |
139,200
-43,600
| -24% | -$3.98M | 0.02% | 815 |
|
|
2022
Q1 | $23.4M | Sell |
182,800
-79,600
| -30% | -$8.71M | 0.02% | 535 |
|
|
2021
Q4 | $35.2M | Sell |
262,400
-208,800
| -44% | -$30M | 0.03% | 420 |
|
|
2021
Q3 | $64.4M | Buy |
471,200
+150,800
| +47% | +$19M | 0.07% | 211 |
|
|
2021
Q2 | $34.2M | Sell |
320,400
-5,600
| -2% | -$538K | 0.04% | 374 |
|
|
2021
Q1 | $29.3M | Sell |
326,000
-96,000
| -23% | -$9.01M | 0.04% | 385 |
|
|
2020
Q4 | $39M | Buy |
422,000
+381,200
| +934% | +$34M | 0.07% | 247 |
|
|
2020
Q3 | $4.21M | Buy |
40,800
+21,600
| +113% | +$2.26M | 0.01% | 1032 |
|
|
2020
Q2 | $1.95M | Sell |
19,200
-34,000
| -64% | -$3.04M | 0.01% | 1486 |
|
|
2020
Q1 | $3.58M | Sell |
53,200
-18,400
| -26% | -$1.14M | 0.03% | 703 |
|
|
2019
Q4 | $3.92M | Buy |
71,600
+54,000
| +307% | +$2.56M | 0.03% | 830 |
|
|
2019
Q3 | $657K | Buy |
17,600
+14,400
| +450% | +$559K | 0.01% | 2105 |
|
|
2019
Q2 | $120K | Buy |
+3,200
| New | +$101K | ﹤0.01% | 3207 |
|
|
2019
Q1 | – | Sell |
-1,600
| Closed | -$48K | – | 4929 |
|
|
2018
Q4 | $48K | Sell |
1,600
-6,000
| -79% | -$190K | ﹤0.01% | 3582 |
|
|
2018
Q3 | $272K | Sell |
7,600
-3,600
| -32% | -$112K | ﹤0.01% | 2782 |
|
|
2018
Q2 | $266K | Sell |
11,200
-38,800
| -78% | -$823K | ﹤0.01% | 2819 |
|
|
2018
Q1 | $927K | Buy |
50,000
+2,400
| +5% | +$35.5K | 0.01% | 1586 |
|
|
2017
Q4 | $683K | Sell |
47,600
-8,000
| -14% | -$104K | ﹤0.01% | 2001 |
|
|
2017
Q3 | $680K | Sell |
55,600
-18,800
| -25% | -$332K | 0.01% | 1843 |
|
|
2017
Q2 | $1.36M | Sell |
74,400
-88,800
| -54% | -$1.64M | 0.01% | 1221 |
|
|
2017
Q1 | $3.46M | Buy |
+163,200
| New | +$3.19M | 0.04% | 563 |
|
|
2016
Q4 | – | Sell |
-11,200
| Closed | -$245K | – | 4498 |
|
|
2016
Q3 | $245K | Buy |
+11,200
| New | +$249K | ﹤0.01% | 2320 |
|
|
2016
Q2 | – | Sell |
-8,000
| Closed | -$136K | – | 4678 |
|
|
2016
Q1 | $136K | Buy |
+8,000
| New | +$134K | ﹤0.01% | 2605 |
|
|
2015
Q4 | – | Sell |
-126,000
| Closed | -$2.71M | – | 4811 |
|
|
2015
Q3 | $2.71M | Buy |
126,000
+56,400
| +81% | +$1.26M | 0.04% | 617 |
|
|
2015
Q2 | $1.39M | Buy |
69,600
+2,000
| +3% | +$35.1K | 0.02% | 970 |
|
|
2015
Q1 | $1.05M | Buy |
67,600
+37,600
| +125% | +$568K | 0.02% | 1037 |
|
|
2014
Q4 | $413K | Sell |
30,000
-56,800
| -65% | -$695K | 0.01% | 1697 |
|
|
2014
Q3 | $868K | Buy |
86,800
+61,200
| +239% | +$626K | 0.01% | 1205 |
|
|
2014
Q2 | $254K | Buy |
25,600
+1,600
| +7% | +$14.2K | ﹤0.01% | 2185 |
|
|
2014
Q1 | $248K | Buy |
+24,000
| New | +$248K | ﹤0.01% | 2260 |
|
Other funds holding DXCM
VCM
VPM
Group One Trading's DXCM Position: Q1 2026 in Review
Group One Trading reduced its DexCom (DXCM) stake by 94% in Q1 2026, selling an estimated $1.92M and leaving 1,706 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #4659.
Group One Trading first reported a position in DXCM in Q4 2013 and has held it in 34 quarters since. The position peaked at $17.3M in Q4 2020. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Group One Trading held 1,706 shares of DexCom worth $107K as of Q1 2026.
- Group One Trading sold 27,571 DexCom shares in Q1 2026, an estimated $1.92M.
- DexCom made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4659 holding.
- Group One Trading first reported a position in DexCom in Q4 2013 and has held it in 34 quarters since.
- Group One Trading's DexCom position peaked at $17.3M in Q4 2020.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.